UPDATE: Synergy Pharma (SGYP) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 Revenues Below Consensus & Below Min. Revenue Covenant on Loan Agreement

Go back to UPDATE: Synergy Pharma (SGYP) Reports In-Line Q3 EPS, Revenues Miss; Lowers FY18 Revenues Below Consensus & Below Min. Revenue Covenant on Loan Agreement
SYNERGY PHARMA (NASDAQ: SGYP) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High $6.58 
Open $59.45    52 Week Low $2.50 
Day High $0.03    P/E N/A 
Day Low $0.03    EPS $-0.70 
Volume 62,153